SMG
NYSE · Chemicals
Scotts Miracle-Gro Co
$62.91
+0.85 (+1.37%)
Financial Highlights (FY 2026)
Revenue
3.43B
Net Income
145.98M
Gross Margin
31.2%
Profit Margin
4.3%
Rev Growth
-4.5%
D/E Ratio
20.11
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 31.2% | 31.2% | 48.1% | 48.1% |
| Operating Margin | 10.5% | 9.5% | 10.5% | 9.6% |
| Profit Margin | 4.3% | 4.0% | 7.4% | 6.9% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 3.43B | 3.59B | 2.16B | 2.15B |
| Gross Profit | 1.07B | 1.12B | 1.04B | 1.04B |
| Operating Income | 360.65M | 340.02M | 226.84M | 207.60M |
| Net Income | 145.98M | 137.63M | 158.81M | 149.46M |
| Gross Margin | 31.2% | 31.2% | 48.1% | 48.1% |
| Operating Margin | 10.5% | 9.5% | 10.5% | 9.6% |
| Profit Margin | 4.3% | 4.0% | 7.4% | 6.9% |
| Rev Growth | -4.5% | -4.5% | +14.3% | +17.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 1.77B | 1.77B | 1.31B | 1.24B |
| Total Equity | 87.93M | 87.93M | 1.85B | 1.78B |
| D/E Ratio | 20.11 | 20.11 | 0.71 | 0.70 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 372.29M | 370.50M | 251.72M | 263.49M |
| Free Cash Flow | — | — | 163.95M | 114.67M |